VIVITROL as a Treatment for Cocaine and Alcohol Dependence
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of VIVITROL (naltrexone for extended-release injectable suspension)
for the treatment of co-occurring cocaine and alcohol dependence
Phase:
Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Collaborators:
Alkermes, Inc. National Institute on Drug Abuse (NIDA)